Found 8 matching trials
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma
PHASE2The purpose of this study is to assess efficacy and tolerance of intra-hepa...
Location
Hôpital Beaujon - Service de Chirurgie
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets
PHASE2The purpose of this study is to evaluate the safety and impact on survival ...
Location
H. Lee Moffitt Cancer Center and Research Institute
Affordable Made-in-India Microspheres for Liver Cancer Therapy
PHASE1Primary liver tumors, with hepatocellular carcinoma (HCC) accounting for 80...
Location
Postgraduate Institute of Medical Education and Research
Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
PHASE1This study will investigate the combination of Ytrium-90 (Y-90) Selective I...
Status
Active Not Recruiting
Location
University of Michigan Rogel Cancer Center
TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets
PHASE2This is an open label study for patients with inoperable metastatic neuroen...
Location
Imperial College NHS Trust
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
NATherasphere will be administered via catheter through the Hepatic Artery to...
Location
Emory University Hospital
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
PHASE2This study is an open label prospective trial of TheraSphere treatment for ...
Location
Johns Hopkins Hospital
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
NAThe objective of this study is to examine critical aspects of radiation exp...
Location
University of Tennessee Medical Center